共 13 条
- [11] Silencing MICAL2 Expression in Pancreatic Cancer Cells rewires the tumor microenvironment through the IL1-a/p38 MAP kinase/STAT-3 axis and Sensitizes Tumors to Immune Checkpoint Blockade therapyCANCER RESEARCH, 2024, 84 (17)Garg, BhartiMose, EvangelineEsparaza, EdgarPatel, JayMedari, RithikaMartsinkovskiy, AlexeiBishop, CarrieGonzalez, GisseleEngler, AdamKatira, ParagTiriac, HerveLowy, Andrew M.
- [12] Effector T-cell cytolytic activity modules derived from CD3+single cells from human primary triple-negative breast cancer (TNBC) in multiple solid tumors to predict response to immune checkpoint blockade therapy (ICB).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Acharya, Chaitanya RamanujLyerly, Herbert K.
- [13] ICT01, an anti-butyrophilin 3A targeted mAb activating g9d2 T cells, induces immune remodeling of the tumor microenvironment and clinical responses in combination with pembrolizumab in patients with advanced solid tumors who failed prior checkpoint inhibitor therapy: EVICTION Trial.CANCER RESEARCH, 2022, 82 (12)Champiat, StephaneWermke, Martinde Bono, JohannMarabelle, AurelienJungels, ChristianeVicier, CecileVey, NorbertList, CatrinWetzko, KatrinRuhnke, LeoGarralda, Elenade Aguiar, Vladimir GalvaoLoRusso, PatriciaKotecki, NuriaDe Gassart, AudeValentin, EmmanuelBrune, PatrickIche, MarinaLeparquier, CelineOlive, DanielFrohna, Paul